Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

The perceived severity of a disease and the impact of the vocabulary used to convey information: using Rasch scaling in a simulated oncological scenario.

Burro R, Savardi U, Annunziata MA, De Paoli P, Bianchi I.

Patient Prefer Adherence. 2018 Dec 3;12:2553-2573. doi: 10.2147/PPA.S175957. eCollection 2018.

2.

Patients and caregivers' unmet information needs in the field of patient education: results from an Italian multicenter exploratory survey.

Truccolo I, Mazzocut M, Cipolat Mis C, Bidoli E, Zotti P, Flora S, Mei L, Apostolico M, Drace C, Ravaioli V, Conficconi A, Cocchi S, Cervi E, Gangeri L, De Paoli P.

Support Care Cancer. 2019 Jun;27(6):2023-2030. doi: 10.1007/s00520-018-4439-z. Epub 2018 Sep 6.

3.

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.

Fornasier G, Taborelli M, Francescon S, Polesel J, Aliberti M, De Paoli P, Baldo P.

Int J Clin Pharm. 2018 Aug;40(4):795-802. doi: 10.1007/s11096-018-0653-5. Epub 2018 May 21.

4.

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies.

Berretta M, Micek A, Lafranconi A, Rossetti S, Di Francia R, De Paoli P, Rossi P, Facchini G.

Oncotarget. 2018 Apr 17;9(29):20807-20815. doi: 10.18632/oncotarget.24829. eCollection 2018 Apr 17.

5.

The effects of presenting oncologic information in terms of opposites in a medical context.

Burro R, Savardi U, Annunziata MA, De Paoli P, Bianchi I.

Patient Prefer Adherence. 2018 Mar 27;12:443-459. doi: 10.2147/PPA.S147091. eCollection 2018.

6.

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis.

Fiorica F, Trovò M, Ottaiano A, Nasti G, Carandina I, Marzola M, De Paoli P, Berretta M.

Oncotarget. 2017 Dec 28;9(12):10734-10744. doi: 10.18632/oncotarget.23754. eCollection 2018 Feb 13.

7.

Coffee Intake Decreases Risk of Postmenopausal Breast Cancer: A Dose-Response Meta-Analysis on Prospective Cohort Studies.

Lafranconi A, Micek A, De Paoli P, Bimonte S, Rossi P, Quagliariello V, Berretta M.

Nutrients. 2018 Jan 23;10(2). pii: E112. doi: 10.3390/nu10020112.

8.

Cancer Targeted Therapy Strategy: The Pathologist's Perspectives.

Alessandrini L, Perin T, Kadare S, Del Pup L, Memeo L, Steffan A, Colarossi L, Berretta M, De Paoli P, Canzonieri V.

Curr Cancer Drug Targets. 2018;18(5):410-420. doi: 10.2174/1568009618666171129145703.

PMID:
29189158
9.

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.

Silvestris N, Ciliberto G, De Paoli P, Apolone G, Lavitrano ML, Pierotti MA, Stanta G; On the behalf of the “dynamic medicine OECI group”.

J Exp Clin Cancer Res. 2017 Sep 13;36(1):128. doi: 10.1186/s13046-017-0598-x. Review.

10.

Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas.

Spessotto P, Fornasarig M, Pivetta E, Maiero S, Magris R, Mongiat M, Canzonieri V, De Paoli P, De Paoli A, Buonadonna A, Serraino D, Panato C, Belluco C, Cannizzaro R.

Sci Rep. 2017 Aug 29;7(1):9819. doi: 10.1038/s41598-017-10963-1.

11.

Teaching Digital Pathology: The International School of Digital Pathology and Proposed Syllabus.

Mea VD, Carbone A, Di Loreto C, Bueno G, De Paoli P, García-Rojo M, de Mena D, Gloghini A, Ilyas M, Laurinavicius A, Rasmusson A, Milione M, Dolcetti R, Pagani M, Stoppini A, Sulfaro S, Bartolo M, Mazzon E, Soyer HP, Pantanowitz L.

J Pathol Inform. 2017 Jul 25;8:27. doi: 10.4103/jpi.jpi_17_17. eCollection 2017.

12.

Cross-cultural validation of health literacy measurement tools in Italian oncology patients.

Zotti P, Cocchi S, Polesel J, Cipolat Mis C, Bragatto D, Cavuto S, Conficconi A, Costanzo C, De Giorgi M, Drace CA, Fiorini F, Gangeri L, Lisi A, Martino R, Mosconi P, Paradiso A, Ravaioli V, Truccolo I, De Paoli P; ICPEG.

BMC Health Serv Res. 2017 Jun 19;17(1):410. doi: 10.1186/s12913-017-2359-0.

13.

Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.

Gloghini A, Volpi CC, Gualeni AV, Dolcetti R, Bongarzone I, De Paoli P, Carbone A.

Expert Rev Hematol. 2017 Jun;10(6):505-514. doi: 10.1080/17474086.2017.1326815. Epub 2017 May 16. Review.

PMID:
28468596
14.

The angiostatic molecule Multimerin 2 is processed by MMP-9 to allow sprouting angiogenesis.

Andreuzzi E, Colladel R, Pellicani R, Tarticchio G, Cannizzaro R, Spessotto P, Bussolati B, Brossa A, De Paoli P, Canzonieri V, Iozzo RV, Colombatti A, Mongiat M.

Matrix Biol. 2017 Dec;64:40-53. doi: 10.1016/j.matbio.2017.04.002. Epub 2017 Apr 21.

PMID:
28435016
15.

Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey.

Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A, Nasti G, Fisichella R, Romano C, De Divitiis C, Taibi R, Fiorica F, Di Francia R, Di Mari A, Del Pup L, Crispo A, De Paoli P, Santorelli A, Quagliariello V, Iaffaioli RV, Tirelli U, Facchini G.

Oncotarget. 2017 Apr 11;8(15):24401-24414. doi: 10.18632/oncotarget.14224.

16.

The persistent problem of late HIV diagnosis in people with AIDS: a population-based study in Italy, 1999-2013.

Taborelli M, Virdone S, Camoni L, Regine V, Zucchetto A, Frova L, Grande E, Boros S, Dal Maso L, De Paoli P, Serraino D, Suligoi B.

Public Health. 2017 Jan;142:39-45. doi: 10.1016/j.puhe.2016.10.009. Epub 2016 Nov 18.

PMID:
28057195
17.

Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma.

Berretta M, Rinaldi L, Di Benedetto F, Lleshi A, De Re V, Facchini G, De Paoli P, Di Francia R.

Front Pharmacol. 2016 Nov 9;7:428. eCollection 2016. Review.

18.

Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study.

Fusco M, Piselli P, Virdone S, Di Cicco P, Scognamiglio P, De Paoli P, Ciullo V, Verdirosi D, D'Orazio M, Dal Maso L, Girardi E, Franceschi S, Serraino D.

Infect Agent Cancer. 2016 Nov 3;11:54. doi: 10.1186/s13027-016-0101-x. eCollection 2016.

19.

The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis.

Carbone A, Gloghini A, Caruso A, De Paoli P, Dolcetti R.

Int J Cancer. 2017 Mar 15;140(6):1233-1245. doi: 10.1002/ijc.30473. Epub 2016 Oct 27. Review.

20.

Focused X-Ray Histological Analyses to Reveal Asbestos Fibers and Bodies in Lungs and Pleura of Asbestos-Exposed Subjects.

Pascolo L, Gianoncelli A, Rizzardi C, de Jonge M, Howard D, Paterson D, Cammisuli F, Salomé M, De Paoli P, Melato M, Canzonieri V.

Microsc Microanal. 2016 Oct;22(5):1062-1071. Epub 2016 Sep 13.

PMID:
27619825
21.

New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy.

Berretta M, Di Francia R, Stanzione B, Facchini G, LLeshi A, De Paoli P, Spina M, Tirelli U.

Expert Opin Pharmacother. 2016 Dec;17(18):2391-2403. Epub 2016 Nov 16. Review.

PMID:
27771974
22.

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

De Re V, De Zorzi M, Caggiari L, Lauletta G, Tornesello ML, Fognani E, Miorin M, Racanelli V, Quartuccio L, Gragnani L, Russi S, Pavone F, Ghersetti M, Costa EG, Casarin P, Bomben R, Mazzaro C, Basaglia G, Berretta M, Vaccher E, Izzo F, Buonaguro FM, De Vita S, Zignego AL, De Paoli P, Dolcetti R.

Oncotarget. 2016 Jun 21;7(25):37487-37497. doi: 10.18632/oncotarget.9303.

23.

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.

De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R.

Clin Transl Gastroenterol. 2016 Jul 21;7(7):e183. doi: 10.1038/ctg.2016.42.

24.

Web Conversations About Complementary and Alternative Medicines and Cancer: Content and Sentiment Analysis.

Mazzocut M, Truccolo I, Antonini M, Rinaldi F, Omero P, Ferrarin E, De Paoli P, Tasso C.

J Med Internet Res. 2016 Jun 16;18(6):e120. doi: 10.2196/jmir.5521.

25.

Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.

Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M.

Tumori. 2015;101 Suppl 1:S6-9. doi: 10.5301/tj.5000464. Epub 2015 Dec 30.

PMID:
27098181
26.

Kaposi's Sarcoma Herpesvirus: twenty years after its discovery.

De Paoli P, Carbone A.

Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1288-94. Review.

27.

Alleanza Contro il Cancro: the accreditation system of the Excellence Network of Italian Cancer Centers in the precision medicine era.

Palombo F, De Paoli P, De Maria R.

Tumori. 2015;101 Suppl 1:S64-6. doi: 10.5301/tj.5000463. Epub 2015 Dec 30.

PMID:
27096277
28.

The OECI model: the CRO Aviano experience.

Da Pieve L, Collazzo R, Masutti M, De Paoli P.

Tumori. 2015;101 Suppl 1:S10-3. doi: 10.5301/tj.5000456. Epub 2015 Dec 30.

PMID:
27096265
29.

International Accreditation of Cancer Centres of Italian Network of Alleanza contro il Cancro: introductory remarks.

Paradiso A, Belardelli F, De Paoli P, De Maria R.

Tumori. 2015;101 Suppl 1:1. doi: 10.5301/tj.5000454. Epub 2015 Dec 30. No abstract available.

PMID:
27096263
30.

Drug-Drug Interactions Based on Pharmacogenetic Profile between Highly Active Antiretroviral Therapy and Antiblastic Chemotherapy in Cancer Patients with HIV Infection.

Berretta M, Caraglia M, Martellotta F, Zappavigna S, Lombardi A, Fierro C, Atripaldi L, Muto T, Valente D, De Paoli P, Tirelli U, Di Francia R.

Front Pharmacol. 2016 Mar 30;7:71. doi: 10.3389/fphar.2016.00071. eCollection 2016. Review.

31.

Drafting biological material transfer agreement: a ready-to-sign model for biobanks and biorepositories.

Cervo S, De Paoli P, Mestroni E, Perin T, Escoffier L, Canzonieri V, Steffan A.

Int J Biol Markers. 2016 May 28;31(2):e211-7. doi: 10.5301/jbm.5000190.

PMID:
26868333
32.

Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.

Cini G, Mezzavilla M, Della Puppa L, Cupelli E, Fornasin A, D'Elia AV, Dolcetti R, Damante G, Bertok S, Miolo G, Maestro R, de Paoli P, Amoroso A, Viel A.

BMC Med Genet. 2016 Feb 6;17:11. doi: 10.1186/s12881-016-0274-6.

33.

Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy.

Gini A, Bidoli E, Zanier L, Clagnan E, Zanette G, Gobbato M, De Paoli P, Serraino D.

Cancer Epidemiol. 2016 Apr;41:80-7. doi: 10.1016/j.canep.2016.01.011. Epub 2016 Feb 3.

PMID:
26851751
34.

Actual costs of cancer drugs in 15 European countries.

van Harten WH, Wind A, de Paoli P, Saghatchian M, Oberst S.

Lancet Oncol. 2016 Jan;17(1):18-20. doi: 10.1016/S1470-2045(15)00486-6. Epub 2015 Dec 4. No abstract available.

PMID:
26670093
35.

Morphologic shift associated with aberrant cytokeratin expression in a GIST patient after tyrosine kinase inhibitors therapy. A case report with a brief review of the literature.

Canzonieri V, Gasparotto D, Alessandrini L, Miolo G, Torrisi E, Perin T, De Paoli P, Maestro R, Buonadonna A.

Pathol Res Pract. 2016 Jan;212(1):63-7. doi: 10.1016/j.prp.2015.11.004. Epub 2015 Nov 10. Review.

PMID:
26616113
36.

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.

Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Muraro E, Rozera G, De Paoli P, Carbone A, Capobianchi MR, Ippolito G, Fiorentini S, Blattner WA, Lu W, Gallo RC, Caruso A.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14331-6. doi: 10.1073/pnas.1514748112. Epub 2015 Nov 2. Erratum in: Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):E7033.

37.

Alliance Against Cancer, the network of Italian cancer centers bridging research and care.

De Paoli P, Ciliberto G, Ferrarini M, Pelicci P, Dellabona P, De Lorenzo F, Mantovani A, Musto P, Opocher G, Picci P, Ricciardi W, De Maria R.

J Transl Med. 2015 Nov 14;13:360. doi: 10.1186/s12967-015-0711-x.

38.

Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.

Bortolin MT, Tedeschi R, Bidoli E, Furlan C, Basaglia G, Minatel E, Gobitti C, Franchin G, Trovò M, De Paoli P.

Biomarkers. 2015;20(6-7):422-8. doi: 10.3109/1354750X.2015.1094139. Epub 2015 Nov 2.

PMID:
26526078
39.

Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

Berretta M, Martellotta F, Di Francia R, Spina M, Vaccher E, Balestreri L, Borsatti E, Bearz A, De Paoli P, Tirelli U.

Eur Rev Med Pharmacol Sci. 2015 Oct;19(19):3619-34.

40.

Postautologous stem cell transplantation long-term outcomes in 26 HIV-positive patients affected by relapsed/refractory lymphoma.

Zanet E, Taborelli M, Rupolo M, Durante C, Mazzucato M, Zanussi S, De Paoli P, Serraino D, Tirelli U, Lleshi A, Michieli M.

AIDS. 2015 Nov;29(17):2303-8. doi: 10.1097/QAD.0000000000000851.

PMID:
26418085
41.

Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma.

Tedeschi R, Bidoli E, Bortolin MT, Schioppa O, Vaccher E, De Paoli P.

Oncotarget. 2015 Oct 6;6(30):30334-42. doi: 10.18632/oncotarget.4571.

42.

Surgery for Liver Metastases From Gastric Cancer: A Meta-Analysis of Observational Studies.

Martella L, Bertozzi S, Londero AP, Steffan A, De Paoli P, Bertola G.

Medicine (Baltimore). 2015 Aug;94(31):e1113. doi: 10.1097/MD.0000000000001113. Review.

43.

Making patient centered care a reality: a survey of patient educational programs in Italian Cancer Research and Care Institutes.

Cipolat Mis C, Truccolo I, Ravaioli V, Cocchi S, Gangeri L, Mosconi P, Drace C, Pomicino L, Paradiso A, De Paoli P; Italian Cancer Patient Education Group.

BMC Health Serv Res. 2015 Jul 30;15:298. doi: 10.1186/s12913-015-0962-5.

44.

Toxicities and Adverse Drug Reactions Experienced During Anticancer Treatment: It Is Desirable to Consider the Problem Within the International System of Pharmacovigilance.

Baldo P, Fornasier G, Francescon S, Ferrarin E, Truccolo I, De Paoli P.

J Clin Oncol. 2015 Sep 1;33(25):2824-5. doi: 10.1200/JCO.2015.61.7613. Epub 2015 Jul 20. No abstract available.

PMID:
26195718
45.

Risk factors for early mortality after AIDS in the cART era: A population-based cohort study in Italy.

Suligoi B, Zucchetto A, Grande E, Camoni L, Dal Maso L, Frova L, Virdone S, Boros S, Pappagallo M, Taborelli M, Regine V, De Paoli P, Serraino D.

BMC Infect Dis. 2015 Jun 12;15:229. doi: 10.1186/s12879-015-0960-6.

46.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

47.

Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.

De Paoli P, Carbone A.

Semin Cancer Biol. 2015 Oct;34:70-80. doi: 10.1016/j.semcancer.2015.03.009. Epub 2015 Mar 30. Review.

48.

Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education Initiatives.

Truccolo I, Cipolat Mis C, Cervo S, Dal Maso L, Bongiovanni M, Bearz A, Sartor I, Baldo P, Ferrarin E, Fratino L, Mascarin M, Roncadin M, Annunziata MA, Muzzatti B, De Paoli P.

J Cancer Educ. 2016 Jun;31(2):405-12. doi: 10.1007/s13187-015-0805-4.

49.

Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.

Cervo S, De Paoli P, Perin T, Canzonieri V, Steffan A.

Int J Biol Markers. 2015 May 26;30(2):e243-51. doi: 10.5301/jbm.5000138.

PMID:
25744364
50.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

Supplemental Content

Loading ...
Support Center